145 related articles for article (PubMed ID: 33302499)
21. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma.
Hong KO; Lee JI; Hong SP; Hong SD
Amino Acids; 2016 Jan; 48(1):117-27. PubMed ID: 26276576
[TBL] [Abstract][Full Text] [Related]
22. Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma.
Ma HL; Jin SF; Ju WT; Fu Y; Tu YY; Wang LZ; Jiang-Li ; Zhang ZY; Zhong LP
J Exp Clin Cancer Res; 2017 Aug; 36(1):109. PubMed ID: 28806997
[TBL] [Abstract][Full Text] [Related]
23. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
[TBL] [Abstract][Full Text] [Related]
24. The role of p300 in the tumor progression of oral squamous cell carcinoma.
Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
[TBL] [Abstract][Full Text] [Related]
25. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines.
Burns JE; Baird MC; Clark LJ; Burns PA; Edington K; Chapman C; Mitchell R; Robertson G; Soutar D; Parkinson EK
Br J Cancer; 1993 Jun; 67(6):1274-84. PubMed ID: 8390283
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated fibroblasts regulate keratinocyte cell-cell adhesion via TGF-β-dependent pathways in genotype-specific oral cancer.
Cirillo N; Hassona Y; Celentano A; Lim KP; Manchella S; Parkinson EK; Prime SS
Carcinogenesis; 2017 Jan; 38(1):76-85. PubMed ID: 27803052
[TBL] [Abstract][Full Text] [Related]
27. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
[TBL] [Abstract][Full Text] [Related]
28. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
Johnson JJ; Miller DL; Jiang R; Liu Y; Shi Z; Tarwater L; Williams R; Balsara R; Sauter ER; Stack MS
J Biol Chem; 2016 Mar; 291(13):6936-45. PubMed ID: 26839311
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.
Zedan W; Mourad MI; El-Aziz SM; Salamaa NM; Shalaby AA
Diagn Pathol; 2015 Feb; 10():2. PubMed ID: 25881131
[TBL] [Abstract][Full Text] [Related]
30. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
31. DOX-MTX-NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes.
Abbasi MM; Khiavi MM; Monfaredan A; Hamishehkar H; Seidi K; Jahanban-Esfahlan R
Asian Pac J Cancer Prev; 2014; 15(19):8377-82. PubMed ID: 25339032
[TBL] [Abstract][Full Text] [Related]
32. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
Roger L; Jullien L; Gire V; Roux P
J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
[TBL] [Abstract][Full Text] [Related]
33. Expression signature and molecular basis of CDH11 in OSCC detected by a combination of multiple methods.
Wei Y; Cheng X; Deng L; Dong H; Wei H; Xie C; Tuo Y; Li G; Yu D; Cao Y
BMC Med Genomics; 2023 Apr; 16(1):70. PubMed ID: 37013637
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous tumorigenicity of primary human oral keratinocytes with human papillomavirus negativity and impaired apoptosis.
Jang DH; Oh JE; Kang HK; Kim OB; Min SK; Jung SY; Hong SD; Lee JI; Min BM
Int J Oncol; 2010 Jun; 36(6):1491-501. PubMed ID: 20428774
[TBL] [Abstract][Full Text] [Related]
35. Presenilin 1/γ-secretase modulates P-cadherin processing and influences cell adhesion in oral squamous cell carcinoma cell lines.
Bauer K; Gosau M; Reinders J; Oefner P; Reichert TE; Bauer R
Carcinogenesis; 2013 Nov; 34(11):2622-8. PubMed ID: 23740836
[TBL] [Abstract][Full Text] [Related]
36. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
37. miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes.
Hung PS; Tu HF; Kao SY; Yang CC; Liu CJ; Huang TY; Chang KW; Lin SC
Carcinogenesis; 2014 May; 35(5):1162-71. PubMed ID: 24480806
[TBL] [Abstract][Full Text] [Related]
38. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
[TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
40. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
